Nursing Management of MS Patients Receiving Interferon Beta-1b Therapy
- 1 March 1997
- journal article
- review article
- Published by Wolters Kluwer Health in Rehabilitation Nursing Journal
- Vol. 22 (2) , 62-66
- https://doi.org/10.1002/j.2048-7940.1997.tb01735.x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosisAnnals of Neurology, 1996
- Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosisNeurology, 1995
- Interferon beta‐lb in the treatment of multiple sclerosisNeurology, 1995
- Multiple sclerosis: Immune mechanism and update on current therapiesAnnals of Neurology, 1995
- Chronic systemic high‐dose recombinant interferon alfa‐2a reduces exacerbation rate, MRI signs of disease activity, and lymphocyte interferon gamma production in relapsing‐remitting multiple sclerosisNeurology, 1994
- Experimental therapy of relapsing-remitting multiple sclerosis with copolymer-1Annals of Neurology, 1994
- The Effect of Corticosteroids for Acute Optic Neuritis on the Subsequent Development of Multiple SclerosisNew England Journal of Medicine, 1993
- Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosisNeurology, 1993
- Systemic Recombinant -2Interferon Therapy in Relapsing Multiple SclerosisArchives of Neurology, 1986
- Systemic alpha‐interferon therapy of multiple sclerosisNeurology, 1984